Clinical Trials Directory

Trials / Unknown

UnknownNCT04580615

Data Collection From the CardiacSense1 and Other Modalities for Developing a System for Monitoring of Respiratory Rate

Anonymized Data Collection From the CardiacSense1 and Other Modalities for the Purpose of Developing a System for Monitoring of Respiratory Rate

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
CardiacSense Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Collect data from the CardiacSense1's sensors and Capnograph, for the purpose of developing a wearable system for monitoring of Respiratory Rate (RR) in patients while at hospital

Detailed description

Hospitalized subjects, diagnosed with a Respiratory disease or subjects with no known Respiratory disease will be will be connected simultaneously to CardiacSense watch and Capnograph for a duration of at least 30 minutes and up to 24 hours in order to collect data for the purpose of developing a wearable system for monitoring of Respiratory Rate (RR) by the CardiacSense watch. The CardiacSense1 is a wrist worn device designed to detect atrial fibrillation. CardiacSense1 senses the radial artery inflation and deflation and together with a PPG sensors give an ultimate performance that is superior to PPG only.

Conditions

Interventions

TypeNameDescription
DEVICECardiacSense1 and capnograph Respiratory rate measurementInpatients Subjects with respiratory disease/impairment and Inpatients Subjects with no known respiratory disease/impairment will be measured simultaneously with both CardiacSense1 and capnograph for at least 30 minutes up to 24 hours. During this time capnograph data will be recorded in parallel to CardiacSense1.

Timeline

Start date
2020-06-03
Primary completion
2022-05-01
Completion
2022-05-01
First posted
2020-10-08
Last updated
2022-01-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04580615. Inclusion in this directory is not an endorsement.